Cleerly · Series C
FDA-cleared AI imaging platform that analyzes coronary CT scans to detect and characterize heart disease earlier.
Amount
$223M
Round
Series C
Valuation
—
Announced
Jul 2022
Investors
Lead investor
T. Rowe PriceNotes
Lead: T. Rowe Price and Fidelity
Other Cleerly rounds
| Date | Round | Amount | |
|---|---|---|---|
| Dec 2024 | Series C Extension | $106M | Details → |